everolimus sandoz everolimus 10 mg tablet blister pack
novartis pharmaceuticals australia pty ltd - everolimus, quantity: 10 mg - tablet, uncoated - excipient ingredients: butylated hydroxytoluene; lactose monohydrate; hypromellose; magnesium stearate; crospovidone; lactose - everolimus sandoz is indicated for the treatment of:,? postmenopausal women with hormone receptor-positive, her2 negative advanced breast cancer in combination with exemestane after failure of treatment with letrozole or anastrozole. ? progressive, unresectable or metastatic, well or moderately differentiated neuroendocrine tumours (nets) of pancreatic origin. ? progressive, unresectable or metastatic, well-differentiated, non-functional neuroendocrine tumours (net) of gastrointestinal or lung origin in adults. ? advanced renal cell carcinoma after failure of treatment with sorafenib or sunitinib. ? subependymal giant cell astrocytoma (sega) associated with tuberous sclerosis complex (tsc) who require therapeutic intervention but are not candidates for curative surgical resection. ? patients with tuberous sclerosis complex (tsc) who have renal angiomyolipoma not requiring immediate surgery.
everolimus sandoz everolimus 5 mg tablet blister pack
novartis pharmaceuticals australia pty ltd - everolimus, quantity: 5 mg - tablet, uncoated - excipient ingredients: butylated hydroxytoluene; lactose monohydrate; hypromellose; magnesium stearate; crospovidone; lactose - everolimus sandoz is indicated for the treatment of:,? postmenopausal women with hormone receptor-positive, her2 negative advanced breast cancer in combination with exemestane after failure of treatment with letrozole or anastrozole. ? progressive, unresectable or metastatic, well or moderately differentiated neuroendocrine tumours (nets) of pancreatic origin. ? progressive, unresectable or metastatic, well-differentiated, non-functional neuroendocrine tumours (net) of gastrointestinal or lung origin in adults. ? advanced renal cell carcinoma after failure of treatment with sorafenib or sunitinib. ? subependymal giant cell astrocytoma (sega) associated with tuberous sclerosis complex (tsc) who require therapeutic intervention but are not candidates for curative surgical resection. ? patients with tuberous sclerosis complex (tsc) who have renal angiomyolipoma not requiring immediate surgery.
everolimus sandoz everolimus 2.5 mg tablet blister pack
novartis pharmaceuticals australia pty ltd - everolimus, quantity: 2.5 mg - tablet - excipient ingredients: magnesium stearate; lactose; lactose monohydrate; hypromellose; butylated hydroxytoluene; crospovidone - everolimus sandoz is indicated for the treatment of:,? postmenopausal women with hormone receptor-positive, her2 negative advanced breast cancer in combination with exemestane after failure of treatment with letrozole or anastrozole. ? progressive, unresectable or metastatic, well or moderately differentiated neuroendocrine tumours (nets) of pancreatic origin. ? progressive, unresectable or metastatic, well-differentiated, non-functional neuroendocrine tumours (net) of gastrointestinal or lung origin in adults. ? advanced renal cell carcinoma after failure of treatment with sorafenib or sunitinib. ? subependymal giant cell astrocytoma (sega) associated with tuberous sclerosis complex (tsc) who require therapeutic intervention but are not candidates for curative surgical resection. ? patients with tuberous sclerosis complex (tsc) who have renal angiomyolipoma not requiring immediate surgery.
everolimus rowex 10mg tablets
rowex ltd - everolimus - tablet - 10 milligram(s) - everolimus; protein kinase inhibitors; everolimus
everolimus rowex 2.5mg tablets
rowex ltd - everolimus - tablet - 2.5 milligram(s) - everolimus; protein kinase inhibitors; everolimus
everolimus rowex 5mg tablets
rowex ltd - everolimus - tablet - 5 milligram(s) - everolimus; protein kinase inhibitors; everolimus
everolimus genthon 2.5mg tablets
genthon bv microweg 22, 6545 cm nijmegen, netherlands - everolimus - tablet - everolimus 2.5 mg - antineoplastic agents
everolimus genthon 5mg tablets
genthon bv microweg 22, 6545 cm nijmegen, netherlands - everolimus - tablet - everolimus 5 mg - antineoplastic agents
everolimus genthon 10mg tablets
genthon bv microweg 22, 6545 cm nijmegen, netherlands - everolimus - tablet - everolimus 10 mg/2ml - antineoplastic agents
teva-everolimus tablet
teva canada limited - everolimus - tablet - 2.5mg - everolimus 2.5mg - antineoplastic agents